NCT00330577View on ClinicalTrials.gov

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

July 31, 2007

Conditions

Primary Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

timolol maleate 0.5%

DRUG

latanoprost/timolol fixed combination

DRUG

placebo (artificial tears)

Trial Locations (1)

546 36

Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital, Thessaloniki

All Listed Sponsors

lead

Aristotle University Of Thessaloniki

OTHER

NCT00330577 - 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients | Biotech Hunter | Biotech Hunter